While it has only been modestly affected, Algeria’s financial sector has not been immune to the effects of the global oil price shock, which is unsurprising given the impact it has on Algeria’s broader macroeconomic climate over the past two years. The excess liquidity that had insulated the banking industry from external shocks was eroded...
With among the largest gas reserves in the world, Algeria is set to emerge as one of the largest international producers of phosphates in the coming years. Together with cheap energy prices and its close proximity to a range of markets, these factors make the country ideally suited to large-scale fertiliser production and export. Domestic...
The Entreprise de Gestion Hôtelière El Aurassi (EGH El Aurassi) is a hotel management firm, with its headquarters in the capital city of Algiers. The Hôtel El Aurassi is the flagship hotel of the firm and one of four hotels in the EGH El Aurassi portfolio. The other three hotels in the management company’s portfolio include Hôtel Rym in Beni...
While it has grown more than five-fold since the 1990s, Algeria’s insurance industry remains small relative to the size of the economy, with low penetration and density ratios – a common feature seen in emerging and frontier market insurance markets. The sector, which was partitioned into life and non-life segments in 2011, still sees more...
Despite the availability of cheap energy and a range of local natural resources, non-hydrocarbons industry in Algeria has been slow to develop. However, amid efforts by the government to prioritise the sector as part of its diversification plans, there are signs that it is beginning to take off, supported by incentives for investment and the...
Biopharm is a pharmaceutical company founded in early 1990. In October 1991 the company began operations with the production of generic drugs. To diversify and develop its business Biopharm started to gradually adapt its organisational structure by creating five subsidiary companies. Besides the industrial production of drugs, which remains...
Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.
Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.
Register Here×